Clinical Trial Update: A Prospective Comparative Study of Autologous Bone Marrow-Derived and Adipose Tissue-Derived Mesenchymal Stem Cells Versus Platelet-Rich Plasma and Standard Therapy in Patients With Organic Erectile Dysfunction [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating autologous bone marrow- and adipose-derived mesenchymal stem cells, platelet-rich plasma, and standard therapy for organic e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erectile Dysfunction

Drugs mentioned

• Autologous adipose tissue-derived mesenchymal stem cells (mesenchymal stem cells (autologous adipose tissue-derived))
• Autologous bone marrow-derived mesenchymal stem cells (bone marrow-derived mesenchymal stem cells)
• Platelet-rich plasma (platelet-rich plasma)
• Standard therapy

Snippet

Sponsor: National Scientific Medical Center, Kazakhstan | Conditions: Erectile Dysfunction | Phase 2 | Status: ACTIVE_NOT_RECRUITING